Bioinova

Bioinova is a Prague-based biotechnology company driving innovation in advanced cell therapies and molecular diagnostics. Founded in 2008 as a spin-off of the Institute of Experimental Medicine of the Czech Academy of Sciences, the company transforms cutting-edge research into real-world clinical solutions, with a strong track record of patents and scientific publications.

We manufacture our own stem cell-based medicinal products, test them in preclinical and clinical studies.

Beyond regenerative medicine, Bioinova actively addresses infection diagnostics and antimicrobial resistance. Its innovations range from PCR sampling kits that remove the need for DNA/RNA isolation, to rapid tests that distinguish viral from bacterial infections—empowering physicians with faster, more precise treatment decisions. 

Through these technologies, Bioinova contributes to personalized medicine and enhances the diagnosis and treatment of diverse diseases.

Quality and compliance are ensured by comprehensive authorizations and certifications, including licenses for the manufacture of medicinal products and the operation of a tissue establishment and tissue bank. Certified under GMP, ISO 9001, and ISO 13485, Bioinova undergoes regular independent audits that ensure the highest standards of its manufacturing standards and control processes.